Medicine, Hepatology Division

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Liver Medicine & Life Sciences
Liver Transplantation Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Transplants Medicine & Life Sciences
Liver Diseases Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Fibrosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Steven L Flamm

Steven L Flamm

Person: Academic

19942021
No photo of Daniel R Ganger

Daniel R Ganger

Person: Academic

19802021
No photo of Richard Green

Richard Green

Person: Academic

19912021

Research Output 1980 2019

A comprehensive pipeline for translational top-down proteomics from a single blood draw

Toby, T. K., Fornelli, L., Srzentić, K., DeHart, C. J., Levitsky, J., Friedewald, J. J. & Kelleher, N. L., Jan 1 2019, In : Nature Protocols. 14, 1, p. 119-152 34 p.

Research output: Contribution to journal › Article

Proteomics
Blood
Pipelines
Fractionation
Mass spectrometry
1 Citation (Scopus)

AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis

American Gastroenterological Association Institute Clinical Guidelines Committee, Feb 1 2019, In : Gastroenterology. 156, 3, p. 748-764 17 p.

Research output: Contribution to journal › Article

Ulcerative Colitis
Practice Guidelines
2 Citations (Scopus)

Age and liver transplantation

Durand, F., Levitsky, J., Cauchy, F., Gilgenkrantz, H., Soubrane, O. & Francoz, C., Apr 1 2019, In : Journal of Hepatology. 70, 4, p. 745-758 14 p.

Research output: Contribution to journal › Review article

Liver Transplantation
Tissue Donors
Transplants
End Stage Liver Disease
Brain Death

Grants 2002 2022

Prot# EDP 305-101: A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects with Non-alcoholic Steatohepatitis (NASH)

Rinella, M. E.

ICON Clinical Research, LLC, Enanta Pharmaceuticals, Inc.

9/11/18 → 9/12/21

Project: Research project

Prot# C928-010: An Open- Label, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamic Signals of DUR-928 in Patients with Alcoholic Hepatitis

Flamm, S. L.

CTI Clinical Trial and Consulting Services, DURECT Corporation

8/30/18 → 8/30/21

Project: Research project

Prot#GS-US-454-4378: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Subjects with Bridging (F3) Fibrosis or Compensated Cirrhosis (F4) due to Nonalcoho

Rinella, M. E.

PRA Health Sciences, Gilead Sciences, Inc.

8/23/18 → 8/23/21

Project: Research project